• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

促甲状腺素抗体与人类促甲状腺激素受体的相互作用。

Interaction of thyroid-stimulating antibodies with the human thyrotrophin receptor.

作者信息

Smith B R, Pyle G A, Petersen V B, Hall R

出版信息

J Endocrinol. 1977 Dec;75(3):401-7. doi: 10.1677/joe.0.0750401.

DOI:10.1677/joe.0.0750401
PMID:201719
Abstract

Thyroid-stimulating antibodies (TSAb) were found to inhibit the binding of labelled thyrotrophin (TSH) to thyroid membranes in a dose-dependent manner and this effect was localized in the Fab part of the TSAb molecule. Analysis of the binding data suggested that TSAb and TSH bound to the same receptor site. Production of cyclic AMP by the thyroid membranes was stimulated by TSAb and TSAb-Fab with a similar time course to that observed with TSH. Kinetic studies indicated that the binding of TSAb to the thyroid membranes was not rate-limiting in the process of stimulation of cyclic AMP production.

摘要

甲状腺刺激抗体(TSAb)被发现能以剂量依赖的方式抑制标记促甲状腺素(TSH)与甲状腺膜的结合,且这种效应定位于TSAb分子的Fab部分。结合数据的分析表明,TSAb和TSH结合到相同的受体位点。TSAb和TSAb-Fab刺激甲状腺膜产生环磷酸腺苷(cAMP),其时间进程与TSH相似。动力学研究表明,在刺激cAMP产生的过程中,TSAb与甲状腺膜的结合不是限速步骤。

相似文献

1
Interaction of thyroid-stimulating antibodies with the human thyrotrophin receptor.促甲状腺素抗体与人类促甲状腺激素受体的相互作用。
J Endocrinol. 1977 Dec;75(3):401-7. doi: 10.1677/joe.0.0750401.
2
Interaction of thyrotrophin with the human thyrotrophin receptor.促甲状腺激素与人促甲状腺激素受体的相互作用。
J Endocrinol. 1977 Dec;75(3):391-400. doi: 10.1677/joe.0.0750391.
3
Identification of separate determinants on the thyrotropin receptor reactive with Graves' thyroid-stimulating antibodies and with thyroid-stimulating blocking antibodies in idiopathic myxedema: these determinants have no homologous sequence on gonadotropin receptors.在特发性黏液性水肿中鉴定促甲状腺素受体上与格雷夫斯病促甲状腺素刺激抗体和促甲状腺素阻断抗体反应的不同决定簇:这些决定簇在促性腺激素受体上没有同源序列。
Mol Endocrinol. 1992 Feb;6(2):168-80. doi: 10.1210/mend.6.2.1349156.
4
Studies on multiple thyroid cell membrane-directed antibodies in Graves' disease.格雷夫斯病中多种甲状腺细胞膜定向抗体的研究。
J Clin Invest. 1985 Nov;76(5):1885-91. doi: 10.1172/JCI112183.
5
Immunology of the thyrotropin receptor.促甲状腺激素受体的免疫学
Immunol Commun. 1976;5(5):345-60. doi: 10.3109/08820137609033853.
6
Unlike thyrotropin, thyroid-stimulating antibodies do not activate phospholipase C in human thyroid slices.与促甲状腺激素不同,甲状腺刺激抗体不会激活人甲状腺切片中的磷脂酶C。
J Clin Invest. 1991 May;87(5):1634-42. doi: 10.1172/JCI115178.
7
Prediction and therapy of intrauterine and late-onset neonatal hyperthyroidism.宫内及迟发性新生儿甲状腺功能亢进症的预测与治疗
J Clin Endocrinol Metab. 1986 Feb;62(2):368-71. doi: 10.1210/jcem-62-2-368.
8
Demonstration of thyroid stimulating activity within H chain fragments of TSAb-IgG by protease digestion and reduction.通过蛋白酶消化和还原在TSAb-IgG的重链片段中证实甲状腺刺激活性。
Clin Endocrinol (Oxf). 1997 Feb;46(2):183-8. doi: 10.1046/j.1365-2265.1997.1110923.x.
9
Comparisons of different assays for the thyroid-stimulating antibody of Graves' disease.不同检测方法对格雷夫斯病促甲状腺素抗体检测结果的比较。
J Clin Endocrinol Metab. 1983 Sep;57(3):603-8. doi: 10.1210/jcem-57-3-603.
10
The interaction of thyroid-stimulating antibodies with solubilised human thyrotrophin receptors.促甲状腺素抗体与可溶性人类促甲状腺激素受体的相互作用。
FEBS Lett. 1977 Nov 1;83(1):63-7. doi: 10.1016/0014-5793(77)80642-x.

引用本文的文献

1
Functional Autoantibodies Targeting G-Protein-Coupled Receptors and Their Clinical Phenotype in Patients with Long-COVID.靶向G蛋白偶联受体的功能性自身抗体及其在长期新冠患者中的临床表型
Int J Mol Sci. 2025 Jul 14;26(14):6746. doi: 10.3390/ijms26146746.
2
Brief Report - Monoclonal Antibodies Illustrate the Difficulties in Measuring Blocking TSH Receptor Antibodies.简报 - 单克隆抗体表明测量阻断 TSH 受体抗体存在困难。
Front Endocrinol (Lausanne). 2022 Jul 15;13:943459. doi: 10.3389/fendo.2022.943459. eCollection 2022.
3
The aptamer BC 007 for treatment of dilated cardiomyopathy: evaluation in Doberman  Pinschers of efficacy and outcomes.
用于治疗扩张型心肌病的适配体BC 007:在杜宾犬中的疗效和结果评估
ESC Heart Fail. 2020 Jun;7(3):844-855. doi: 10.1002/ehf2.12628. Epub 2020 Mar 24.
4
The thyrotrophin receptor.促甲状腺激素受体
Springer Semin Immunopathol. 1982;5(4):413-31. doi: 10.1007/BF01857428.
5
Binding of solubilized human TSH-receptor protein by peripheral blood lymphocytes of patients with Graves' disease.格雷夫斯病患者外周血淋巴细胞对可溶性人促甲状腺激素受体蛋白的结合
J Endocrinol Invest. 1981 Apr-Jun;4(2):161-6. doi: 10.1007/BF03350445.
6
The thyrotropin receptor and its role in Graves' disease.
J Endocrinol Invest. 1985 Apr;8(2):175-82. doi: 10.1007/BF03350678.